EV/EBITDA - CK Life Sciences Intl (Holdings) Inc (HKEX:775) - Alpha Spread

CK Life Sciences Intl (Holdings) Inc
HKEX:775

Watchlist Manager
CK Life Sciences Intl (Holdings) Inc Logo
CK Life Sciences Intl (Holdings) Inc
HKEX:775
Watchlist
Price: 0.36 HKD 1.41% Market Closed
Market Cap: 3.5B HKD
Have any thoughts about
CK Life Sciences Intl (Holdings) Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

20.5
Current
20.8
Median
4.8
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
20.5
=
Enterprise Value
6.7B HKD
/
EBITDA
324.7m HKD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More